urapidil has been researched along with adenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiero, R; Bernies, M; Bossi, IM; Cassagneau, B; Cugno, M; Di Mario, C; Fajadet, J; Farah, B; Gregorini, L; Grossi, A; Heusch, G; Kozàkovà, M; Marco, J; Palombo, C | 1 |
| Frenguelli, BG; Pearson, T | 1 |
1 trial(s) available for urapidil and adenosine
| Article | Year |
|---|---|
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Blood Flow Velocity; Blood Pressure; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Stents; Vascular Patency; Yohimbine | 2002 |
1 other study(ies) available for urapidil and adenosine
| Article | Year |
|---|---|
Adrenoceptor subtype-specific acceleration of the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampus.
Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Drug Interactions; Excitatory Postsynaptic Potentials; Female; Hippocampus; Hypoxia; In Vitro Techniques; Isoproterenol; Male; Neural Inhibition; Neurons; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Synaptic Transmission; Time Factors; Yohimbine | 2004 |